The DOI matches its Crossref record; 183 of the 183 references it cites were found in a registry or an index.
The Role of Astrocytes in Multiple Sclerosis
Open accessAbstract
The role traditionally assigned to astrocytes in the pathogenesis of multiple sclerosis (MS) lesions has been the formation of the glial scar once inflammation has subsided. Astrocytes are now recognized to be early and highly active players during lesion formation and key for providing peripheral immune cells access to the central nervous system. Here, we review the role of astrocytes in the formation and evolution of MS lesions, including the recently described functional polarization of astrocytes, discuss prototypical pathways for astrocyte activation, and summarize mechanisms by which MS treatments affect astrocyte function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurotoxic reactive astrocytes are induced by activated microglia
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971
Astrocytes: Biology and pathology
Sofroniew, M. V., & Vinters, H. V. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0619-8 · Cited by 5,196
The M1 and M2 paradigm of macrophage activation: Time for reassessment
Martinez, F. O., & Gordon, S. (2014) · F1000Prime Reports · doi:10.12703/p6-13 · Cited by 4,689
Neurotrophins: Roles in Neuronal Development and Function
Huang, E. J., & Reichardt, L. F. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.677 · Cited by 4,394
Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., & Yamamoto, M. (1999) · Genes & Development · doi:10.1101/gad.13.1.76 · Cited by 3,634
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
The International Multiple Sclerosis Genetics Consortium & The Wellcome Trust Case Control Consortium 2 (2011) · Nature · doi:10.1038/nature10251 · Cited by 2,697
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
Kappos, L., Radue, E.-W., O'Connor, P., Polman, C., Hohlfeld, R., Calabresi, P., Selmaj, K., Agoropoulou, C., Leyk, M., Zhang-Auberson, L., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909494 · Cited by 2,644
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1
Matloubian, M., Lo, C. G., Cinamon, G., Lesneski, M. J., Xu, Y., Brinkmann, V., Allende, M. L., Proia, R. L., & Cyster, J. G. (2004) · Nature · doi:10.1038/nature02284 · Cited by 2,581
The gut microbiota influences blood-brain barrier permeability in mice
Braniste, V., Al-Asmakh, M., Kowal, C., Anuar, F., Abbaspour, A., Tóth, M., Korecka, A., Bakocevic, N., Ng, L. G., Kundu, P., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009759 · Cited by 2,530
Genomic analysis of reactive astrogliosis
Zamanian, J. L., Xu, L., Foo, L. C., Nouri, N., Zhou, L., Giffard, R. G., & Barres, B. A. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.6221-11.2012 · Cited by 2,404 · cited 1×
“It has been proposed that although reactive astrocytes share common properties, they also display unique cellular and molecular features that are specific to different neuropathologies (70, 71).”
BackgroundSignaling to NF-κB by Toll-like receptors
Kawai, T., & Akira, S. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.09.002 · Cited by 2,388
Reactive Astrocytes: Production, Function, and Therapeutic Potential
Liddelow, S. A., & Barres, B. A. (2017) · Immunity · doi:10.1016/j.immuni.2017.06.006 · Cited by 2,336
Genetic and epigenetic fine mapping of causal autoimmune disease variants
Farh, K. K.-H., Marson, A., Zhu, J., Kleinewietfeld, M., Housley, W. J., Beik, S., Shoresh, N., Whitton, H., Ryan, R. J. H., Shishkin, A. A., et al. (2015) · Nature · doi:10.1038/nature13835 · Cited by 1,956
Denison, M. S., & Nagy, S. R. (2003) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.135828 · Cited by 1,895 · cited 1×
“AHR target genes encode for drug-metabolizing enzymes and proteins controlling cell proliferation, differentiation, and apoptosis (139, 140).”
BackgroundCortical demyelination and diffuse white matter injury in multiple sclerosis
Kutzelnigg, A., Lucchinetti, C. F., Stadelmann, C., Brück, W., Rauschka, H., Bergmann, M., Schmidbauer, M., Parisi, J. E., & Lassmann, H. (2005) · Brain · doi:10.1093/brain/awh641 · Cited by 1,836
Multiple Sclerosis — The Plaque and Its Pathogenesis
Frohman, E. M., Racke, M. K., & Raine, C. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052130 · Cited by 1,740
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
Gold, R., Kappos, L., Arnold, D. L., Bar-Or, A., Giovannoni, G., Selmaj, K., Tornatore, C., Sweetser, M. T., Yang, M., Sheikh, S. I., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1114287 · Cited by 1,733
NF-κB, the first quarter-century: remarkable progress and outstanding questions
Hayden, M. S., & Ghosh, S. (2012) · Genes & Development · doi:10.1101/gad.183434.111 · Cited by 1,693
IL‐6: Regulator of Treg/Th17 balance
Kimura, A., & Kishimoto, T. (2010) · European Journal of Immunology · doi:10.1002/eji.201040391 · Cited by 1,595
Rothhammer, V., Mascanfroni, I. D., Bunse, L., Takenaka, M. C., Kenison, J. E., Mayo, L., Chao, C.-C., Patel, B., Yan, R., Blain, M., et al. (2016) · Nature Medicine · doi:10.1038/nm.4106 · Cited by 1,559
Magliozzi, R., Howell, O., Vora, A., Serafini, B., Nicholas, R., Puopolo, M., Reynolds, R., & Aloisi, F. (2006) · Brain · doi:10.1093/brain/awm038 · Cited by 1,443
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
International Multiple Sclerosis Genetics Consortium (IMSGC) (2013) · Nature Genetics · doi:10.1038/ng.2770 · Cited by 1,386
Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
Fox, R. J., Miller, D. H., Phillips, J. T., Hutchinson, M., Havrdova, E., Kita, M., Yang, M., Raghupathi, K., Novas, M., Sweetser, M. T., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1206328 · Cited by 1,355
Alterations of the human gut microbiome in multiple sclerosis
Jangi, S., Gandhi, R., Cox, L. M., Li, N., von Glehn, F., Yan, R., Patel, B., Mazzola, M. A., Liu, S., Glanz, B. L., et al. (2016) · Nature Communications · doi:10.1038/ncomms12015 · Cited by 1,307
Astrocytes are active players in cerebral innate immunity
Farina, C., Aloisi, F., & Meinl, E. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.01.005 · Cited by 1,304 · cited 2×
“Astrocytes play multiple roles in the evolution of MS lesions, not only by recruiting lymphocytes (19, 20) and contributing to tissue damage (21–24) but also by confining inflammation and promoting lesion repair (18).”
BackgroundCommensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination
Berer, K., Mues, M., Koutrolos, M., Rasbi, Z. A., Boziki, M., Johner, C., Wekerle, H., & Krishnamoorthy, G. (2011) · Nature · doi:10.1038/nature10554 · Cited by 1,251
Astrocyte barriers to neurotoxic inflammation
Sofroniew, M. V. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3898 · Cited by 1,202
Interleukin-6, a Major Cytokine in the Central Nervous System
Erta, M., Quintana, A., & Hidalgo, J. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.4679 · Cited by 1,087
von Bartheld, C. S., Bahney, J., & Herculano‐Houzel, S. (2016) · Journal of Comparative Neurology · doi:10.1002/cne.24040 · Cited by 1,063
Innate immunity in the central nervous system
Ransohoff, R. M., & Brown, M. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58644 · Cited by 1,034 · cited 2×
“Astrocytes play multiple roles in the evolution of MS lesions, not only by recruiting lymphocytes (19, 20) and contributing to tissue damage (21–24) but also by confining inflammation and promoting lesion repair (18).”
BackgroundProgressive multiple sclerosis: pathology and pathogenesis
Lassmann, H., van Horssen, J., & Mahad, D. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.168 · Cited by 1,033
Multiple Sclerosis: Current Knowledge and Future Outlook
Kamm, C. P., Uitdehaag, B. M., & Polman, C. H. (2014) · European Neurology · doi:10.1159/000360528 · Cited by 1,010
Sørensen, T. L., Tani, M., Jensen, J., Pierce, V., Lucchinetti, C., Folcik, V. A., Qin, S., Rottman, J., Sellebjerg, F., Strieter, R. M., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5150 · Cited by 1,002
Broad Expression of Toll-Like Receptors in the Human Central Nervous System
Bsibsi, M., Ravid, R., Gveric, D., & van Noort, J. M. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.11.1013 · Cited by 999
Okada, S., Nakamura, M., Katoh, H., Miyao, T., Shimazaki, T., Ishii, K., Yamane, J., Yoshimura, A., Iwamoto, Y., Toyama, Y., et al. (2006) · Nature Medicine · doi:10.1038/nm1425 · Cited by 968
STAT3 is a Critical Regulator of Astrogliosis and Scar Formation after Spinal Cord Injury
Herrmann, J. E., Imura, T., Song, B., Qi, J., Ao, Y., Nguyen, T. K., Korsak, R. A., Takeda, K., Akira, S., & Sofroniew, M. V. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1709-08.2008 · Cited by 958 · cited 1×
“STAT3 signaling in astrocytes plays a beneficial role in CNS inflammation, as demonstrated in mice with conditional, astrocyte-specific knockout of STAT3, where spinal cord injury lesions exhibited increased demyelination, contained more infiltrating dendritic cells, and had attenuated astrocyte hypertrophy and glial…”
BackgroundNF-kappaB Signaling Pathways in Neurological Inflammation: A Mini Review
Shih, R.-H., Wang, C.-Y., & Yang, C.-M. (2015) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2015.00077 · Cited by 910
Three-Dimensional Relationships between Hippocampal Synapses and Astrocytes
Ventura, R., & Harris, K. M. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-16-06897.1999 · Cited by 880
Astrocytes Control Synapse Formation, Function, and Elimination
Chung, W.-S., Allen, N. J., & Eroglu, C. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a020370 · Cited by 839
Calabresi, P. A., Radue, E.-W., Goodin, D., Jeffery, D., Rammohan, K. W., Reder, A. T., Vollmer, T., Agius, M. A., Kappos, L., Stites, T., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70049-3 · Cited by 825
NMDA receptors are expressed in oligodendrocytes and activated in ischaemia
Káradóttir, R., Cavelier, P., Bergersen, L. H., & Attwell, D. (2005) · Nature · doi:10.1038/nature04302 · Cited by 772
The adhesion molecule and cytokine profile of multiple sclerosis lesions
Cannella, B., & Raine, C. S. (1995) · Annals of Neurology · doi:10.1002/ana.410370404 · Cited by 763
Astrocytes: a central element in neurological diseases
Pekny, M., Pekna, M., Messing, A., Steinhäuser, C., Lee, J.-M., Parpura, V., Hol, E. M., Sofroniew, M. V., & Verkhratsky, A. (2016) · Acta Neuropathologica · doi:10.1007/s00401-015-1513-1 · Cited by 755
Neuron-glia metabolic coupling and plasticity
Magistretti, P. J. (2011) · Experimental Physiology · doi:10.1113/expphysiol.2010.053157 · Cited by 747
A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis
Magliozzi, R., Howell, O. W., Reeves, C., Roncaroli, F., Nicholas, R., Serafini, B., Aloisi, F., & Reynolds, R. (2010) · Annals of Neurology · doi:10.1002/ana.22230 · Cited by 747
Glutamate excitotoxicity in a model of multiple sclerosis
Pitt, D., Werner, P., & Raine, C. S. (2000) · Nature Medicine · doi:10.1038/71555 · Cited by 744
Self-citationTLR signaling tailors innate immune responses in human microglia and astrocytes
Jack, C. S., Arbour, N., Manusow, J., Montgrain, V., Blain, M., McCrea, E., Shapiro, A., & Antel, J. P. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4320 · Cited by 734
An updated histological classification system for multiple sclerosis lesions
Kuhlmann, T., Ludwin, S., Prat, A., Antel, J., Brück, W., & Lassmann, H. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1653-y · Cited by 692
Brambilla, R., Bracchi-Ricard, V., Hu, W.-H., Frydel, B., Bramwell, A., Karmally, S., Green, E. J., & Bethea, J. R. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041918 · Cited by 586
(2010) · Progress in Brain Research · doi:10.1016/b978-0-444-53630-3.00008-7 · Cited by 584
Choi, J. W., Gardell, S. E., Herr, D. R., Rivera, R., Lee, C.-W., Noguchi, K., Teo, S. T., Yung, Y. C., Lu, M., Kennedy, G., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014154108 · Cited by 581
NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia
Micu, I., Jiang, Q., Coderre, E., Ridsdale, A., Zhang, L., Woulfe, J., Yin, X., Trapp, B. D., McRory, J. E., Rehak, R., et al. (2006) · Nature · doi:10.1038/nature04474 · Cited by 505
Nylander, A., & Hafler, D. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58649 · Cited by 495
Krumbholz, M., Theil, D., Derfuss, T., Rosenwald, A., Schrader, F., Monoranu, C.-M., Kalled, S. L., Hess, D. M., Serafini, B., Aloisi, F., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041674 · Cited by 492
Werner, P., Pitt, D., & Raine, C. S. (2001) · Annals of Neurology · doi:10.1002/ana.1077 · Cited by 486
Self-citationThe cuprizone animal model: new insights into an old story
Kipp, M., Clarner, T., Dang, J., Copray, S., & Beyer, C. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0591-3 · Cited by 481
Neurosteroidogenesis in Astrocytes, Oligodendrocytes, and Neurons of Cerebral Cortex of Rat Brain
Zwain, I. H. (1999) · Endocrinology · doi:10.1210/en.140.8.3843 · Cited by 473
Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation
Mayo, L., Trauger, S. A., Blain, M., Nadeau, M., Patel, B., Alvarez, J. I., Mascanfroni, I. D., Yeste, A., Kivisäkk, P., Kallas, K., et al. (2014) · Nature Medicine · doi:10.1038/nm.3681 · Cited by 472
Autoimmune encephalomyelitis ameliorated by AMPA antagonists
Smith, T., Groom, A., Zhu, B., & Turski, L. (2000) · Nature Medicine · doi:10.1038/71548 · Cited by 467
Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T
Srinivasan, R., Sailasuta, N., Hurd, R., Nelson, S., & Pelletier, D. (2005) · Brain · doi:10.1093/brain/awh467 · Cited by 465
Scannevin, R. H., Chollate, S., Jung, M.-Y., Shackett, M., Patel, H., Bista, P., Zeng, W., Ryan, S., Yamamoto, M., Lukashev, M., et al. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.190132 · Cited by 461
A neuron–glia signalling network in the active brain
Bezzi, P., & Volterra, A. (2001) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00223-3 · Cited by 446
B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes
Stern, J. N. H., Yaari, G., Vander Heiden, J. A., Church, G., Donahue, W. F., Hintzen, R. Q., Huttner, A. J., Laman, J. D., Nagra, R. M., Nylander, A., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008879 · Cited by 441
Self-citationFritsche, E., Schäfer, C., Calles, C., Bernsmann, T., Bernshausen, T., Wurm, M., Hübenthal, U., Cline, J. E., Hajimiragha, H., Schroeder, P., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701764104 · Cited by 437
Love, S., Louis, D., & Ellison, D. W. (2008) · CRC Press eBooks · doi:10.1201/b22602 · Cited by 435
Pham, T. H. M., Okada, T., Matloubian, M., Lo, C. G., & Cyster, J. G. (2008) · Immunity · doi:10.1016/j.immuni.2007.11.017 · Cited by 427
Stadelmann, C., Kerschensteiner, M., Misgeld, T., Brück, W., Hohlfeld, R., & Lassmann, H. (2002) · Brain · doi:10.1093/brain/awf015 · Cited by 425
Human Astrocytes: Secretome Profiles of Cytokines and Chemokines
Choi, S. S., Lee, H. J., Lim, I., Satoh, J.-I., & Kim, S. U. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092325 · Cited by 408
Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis
Cohen, J. A., & Chun, J. (2011) · Annals of Neurology · doi:10.1002/ana.22426 · Cited by 393
Skripuletz, T., Hackstette, D., Bauer, K., Gudi, V., Pul, R., Voss, E., Berger, K., Kipp, M., Baumgärtner, W., & Stangel, M. (2013) · Brain · doi:10.1093/brain/aws262 · Cited by 376
Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis
Comi, G., Jeffery, D., Kappos, L., Montalban, X., Boyko, A., Rocca, M. A., & Filippi, M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1104318 · Cited by 364
The role of JAK-STAT signaling within the CNS
Nicolas, C. S., Amici, M., Bortolotto, Z. A., Doherty, A., Csaba, Z., Fafouri, A., Dournaud, P., Gressens, P., Collingridge, G. L., & Peineau, S. (2013) · JAK-STAT · doi:10.4161/jkst.22925 · Cited by 351
Sodium chloride inhibits the suppressive function of FOXP3+ regulatory T cells
Hernandez, A. L., Kitz, A., Wu, C., Lowther, D. E., Rodriguez, D. M., Vudattu, N., Deng, S., Herold, K. C., Kuchroo, V. K., Kleinewietfeld, M., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci81151 · Cited by 338
Edg8/S1P5: An Oligodendroglial Receptor with Dual Function on Process Retraction and Cell Survival
Jaillard, C., Harrison, S., Stankoff, B., Aigrot, M. S., Calver, A. R., Duddy, G., Walsh, F. S., Pangalos, M. N., Arimura, N., Kaibuchi, K., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4645-04.2005 · Cited by 338
Environmental factors in multiple sclerosis
Ascherio, A. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2013.865866 · Cited by 330
RelB, a New Partner of Aryl Hydrocarbon Receptor-Mediated Transcription
Vogel, C. F. A., Sciullo, E., Li, W., Wong, P., Lazennec, G., & Matsumura, F. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0211 · Cited by 319
Hafler, D. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21357 · Cited by 315
Cytokines: Powerful Regulators of Glial Cell Activation
John, G. R., Lee, S. C., & Brosnan, C. F. (2003) · The Neuroscientist · doi:10.1177/1073858402239587 · Cited by 300
Acquiring signalling specificity from the cytokine receptor gp130
Ernst, M. (2004) · Trends in Genetics · doi:10.1016/j.tig.2003.11.003 · Cited by 299
Toll‐like receptor 3 on adult human astrocytes triggers production of neuroprotective mediators
Bsibsi, M., Persoon‐Deen, C., Verwer, R. W. H., Meeuwsen, S., Ravid, R., & Van Noort, J. M. (2006) · Glia · doi:10.1002/glia.20328 · Cited by 297
An introduction to the molecular basics of aryl hydrocarbon receptor biology
Abel, J., & Haarmann-Stemmann, T. (2010) · Biological Chemistry · doi:10.1515/bc.2010.128 · Cited by 296
Adhesion molecule expression and regulation on cells of the central nervous system
Lee, S. J., & Benveniste, E. N. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00084-3 · Cited by 296
Fas ligand/Fas system in the brain: regulator of immune and apoptotic responses
Choi, C., & Benveniste, E. N. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2003.08.007 · Cited by 270
Brambilla, R., Persaud, T., Hu, X., Karmally, S., Shestopalov, V. I., Dvoriantchikova, G., Ivanov, D., Nathanson, L., Barnum, S. R., & Bethea, J. R. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802954 · Cited by 264
The astrocyte in multiple sclerosis revisited
Brosnan, C. F., & Raine, C. S. (2013) · Glia · doi:10.1002/glia.22443 · Cited by 259
Preferential expression and function of Toll-like receptor 3 in human astrocytes
Farina, C., Krumbholz, M., Giese, T., Hartmann, G., Aloisi, F., & Meinl, E. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.09.009 · Cited by 256
Gap Junctions Couple Astrocytes and Oligodendrocytes
Orthmann-Murphy, J. L., Abrams, C. K., & Scherer, S. S. (2008) · Journal of Molecular Neuroscience · doi:10.1007/s12031-007-9027-5 · Cited by 247
ATP‐induced ATP release from astrocytes
Anderson, C. M., Bergher, J. P., & Swanson, R. A. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02204.x · Cited by 242
Neuroprotection mediated through estrogen receptor-α in astrocytes
Spence, R. D., Hamby, M. E., Umeda, E., Itoh, N., Du, S., Wisdom, A. J., Cao, Y., Bondar, G., Lam, J., Ao, Y., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103833108 · Cited by 234
Impaired neurosteroid synthesis in multiple sclerosis
Noorbakhsh, F., Ellestad, K. K., Maingat, F., Warren, K. G., Han, M. H., Steinman, L., Baker, G. B., & Power, C. (2011) · Brain · doi:10.1093/brain/awr200 · Cited by 232
Myelin phagocytosis by astrocytes after myelin damage promotes lesion pathology
Ponath, G., Ramanan, S., Mubarak, M., Housley, W., Lee, S., Sahinkaya, F. R., Vortmeyer, A., Raine, C. S., & Pitt, D. (2017) · Brain · doi:10.1093/brain/aww298 · Cited by 232
Self-citationBechmann, I., Mor, G., Nilsen, J., Eliza, M., Nitsch, R., & Naftolin, F. (1999) · Glia · doi:10.1002/(sici)1098-1136(199907)27:1<62::aid-glia7>3.0.co;2-s · Cited by 225
Astrocytic tight junctions control inflammatory CNS lesion pathogenesis
Horng, S., Therattil, A., Moyon, S., Gordon, A., Kim, K., Argaw, A. T., Hara, Y., Mariani, J. N., Sawai, S., Flodby, P., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci91301 · Cited by 221
Act1 mediates IL-17-induced EAE pathogenesis selectively in NG2+ glial cells
Kang, Z., Wang, C., Zepp, J., Wu, L., Sun, K., Zhao, J., Chandrasekharan, U., DiCorleto, P. E., Trapp, B. D., Ransohoff, R. M., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3505 · Cited by 218
Progesterone Synthesis in the Nervous System: Implications for Myelination and Myelin Repair
Schumacher, M., Hussain, R., Gago, N., Oudinet, J.-P., Mattern, C., & Ghoumari, A. M. (2012) · Frontiers in Neuroscience · doi:10.3389/fnins.2012.00010 · Cited by 217
Control of autoimmune CNS inflammation by astrocytes
Rothhammer, V., & Quintana, F. J. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0515-3 · Cited by 214
Environmental Risk Factors for Multiple Sclerosis: A Review with a Focus on Molecular Mechanisms
O’Gorman, C., Lucas, R., & Taylor, B. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms130911718 · Cited by 209
Astrocyte-Derived BDNF Supports Myelin Protein Synthesis after Cuprizone-Induced Demyelination
Fulmer, C. G., VonDran, M. W., Stillman, A. A., Huang, Y., Hempstead, B. L., & Dreyfus, C. F. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.4267-13.2014 · Cited by 204
Sphingosine‐1‐phosphate induces proliferation and morphological changes of neural progenitor cells
Harada, J., Foley, M., Moskowitz, M. A., & Waeber, C. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02219.x · Cited by 203
Linker, R. A., Lee, D.-H., Demir, S., Wiese, S., Kruse, N., Siglienti, I., Gerhardt, E., Neumann, H., Sendtner, M., Luhder, F., et al. (2010) · Brain · doi:10.1093/brain/awq179 · Cited by 202
Immune Players in the CNS: The Astrocyte
Jensen, C. J., Massie, A., & De Keyser, J. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9480-6 · Cited by 202
Sphingosine 1‐phosphate receptor 1 and 3 are upregulated in multiple sclerosis lesions
Van Doorn, R., Van Horssen, J., Verzijl, D., Witte, M., Ronken, E., Van Het Hof, B., Lakeman, K., Dijkstra, C. D., Van Der Valk, P., Reijerkerk, A., et al. (2010) · Glia · doi:10.1002/glia.21021 · Cited by 201
Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis
Marta, M., Andersson, Å., Isaksson, M., Kämpe, O., & Lobell, A. (2008) · European Journal of Immunology · doi:10.1002/eji.200737187 · Cited by 198
A new cross-talk between the aryl hydrocarbon receptor and RelB, a member of the NF-κB family
Vogel, C. F. A., & Matsumura, F. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.09.036 · Cited by 195
Chemical proteomic map of dimethyl fumarate–sensitive cysteines in primary human T cells
Blewett, M. M., Xie, J., Zaro, B. W., Backus, K. M., Altman, A., Teijaro, J. R., & Cravatt, B. F. (2016) · Science Signaling · doi:10.1126/scisignal.aaf7694 · Cited by 194
Brennan, M. S., Matos, M. F., Li, B., Hronowski, X., Gao, B., Juhasz, P., Rhodes, K. J., & Scannevin, R. H. (2015) · PLOS ONE · doi:10.1371/journal.pone.0120254 · Cited by 188
Aryl hydrocarbon receptor activation by cAMP vs. dioxin: Divergent signaling pathways
Oesch-Bartlomowicz, B., Huelster, A., Wiss, O., Antoniou-Lipfert, P., Dietrich, C., Arand, M., Weiss, C., Bockamp, E., & Oesch, F. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503488102 · Cited by 185
Spence, R. D., Wisdom, A. J., Cao, Y., Hill, H. M., Mongerson, C. R. L., Stapornkul, B., Itoh, N., Sofroniew, M. V., & Voskuhl, R. R. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0886-13.2013 · Cited by 182
Kim, R. Y., Hoffman, A. S., Itoh, N., Ao, Y., Spence, R., Sofroniew, M. V., & Voskuhl, R. R. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.06.009 · Cited by 178
Ah receptor and NF-κB interactions: mechanisms and physiological implications
Tian, Y., Rabson, A. B., & Gallo, M. A. (2002) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00068-6 · Cited by 176
Yang, J.-S., Xu, L.-Y., Xiao, B.-G., Hedlund, G., & Link, H. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.02.016 · Cited by 175
DMF, but not other fumarates, inhibits NF-κB activity in vitro in an Nrf2-independent manner
Gillard, G. O., Collette, B., Anderson, J., Chao, J., Scannevin, R. H., Huss, D. J., & Fontenot, J. D. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.04.006 · Cited by 173
Michel, L., Touil, H., Pikor, N. B., Gommerman, J. L., Prat, A., & Bar-Or, A. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00636 · Cited by 173
Nuclear factor kappa B (NF-κB) in multiple sclerosis pathology
Guire, C. M., Prinz, M., Beyaert, R., & Loo, G. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.08.001 · Cited by 172
Pébay, A., Toutant, M., Prémont, J., Calvo, C., Venance, L., Cordier, J., Glowinski, J., & Tencé, M. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01585.x · Cited by 171
Multiple sclerosis: relevance of Class I and Class II MHC-expressing cells to lesion development
Traugott, U. (1987) · Journal of Neuroimmunology · doi:10.1016/0165-5728(87)90082-8 · Cited by 171
Modulation of astrocytic metabolic phenotype by proinflammatory cytokines
Gavillet, M., Allaman, I., & Magistretti, P. J. (2008) · Glia · doi:10.1002/glia.20671 · Cited by 170
Gold, R., Linker, R. A., & Stangel, M. (2012) · Clinical Immunology · doi:10.1016/j.clim.2011.02.017 · Cited by 170
B Cell Receptor and BAFF Receptor Signaling Regulation of B Cell Homeostasis
Khan, W. N. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0800933 · Cited by 169
Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination
Brück, W., Pförtner, R., Pham, T., Zhang, J., Hayardeny, L., Piryatinsky, V., Hanisch, U.-K., Regen, T., van Rossum, D., Brakelmann, L., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1009-1 · Cited by 168
Madhukar, B. V., Brewster, D. W., & Matsumura, F. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.23.7407 · Cited by 164
Akwa, Y., Sananès, N., Gouézou, M., Robel, P., Baulieu, E. E., & Le Goascogne, C. (1993) · The Journal of cell biology · doi:10.1083/jcb.121.1.135 · Cited by 164
Cerciat, M., Unkila, M., Garcia‐Segura, L. M., & Arevalo, M. ‐. (2010) · Glia · doi:10.1002/glia.20904 · Cited by 160
Lehmann, J. C. U., Listopad, J. J., Rentzsch, C. U., Igney, F. H., von Bonin, A., Hennekes, H. H., Asadullah, K., & Docke, W.-D. F. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700686 · Cited by 158
Touil, T., Fitzgerald, D. C., Zhang, G., Rostami, A. M., & Gran, B. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.7505 · Cited by 152
Fingolimod may support neuroprotection via blockade of astrocyte nitric oxide
Colombo, E., Dario, M. D., Capitolo, E., Chaabane, L., Newcombe, J., Martino, G., & Farina, C. (2014) · Annals of Neurology · doi:10.1002/ana.24217 · Cited by 151
Inactivation of astroglial NF‐κB promotes survival of retinal neurons following ischemic injury
Dvoriantchikova, G., Barakat, D. J., Brambilla, R., Agudelo, C., Hernandez, E., Bethea, J. R., Shestopalov, V. I., & Ivanov, D. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06814.x · Cited by 148
Kaye, J., Piryatinsky, V., Birnberg, T., Hingaly, T., Raymond, E., Kashi, R., Amit‐Romach, E., Caballero, I. S., Towfic, F., Ator, M. A., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1607843113 · Cited by 148
Colombo, E., Cordiglieri, C., Melli, G., Newcombe, J., Krumbholz, M., Parada, L. F., Medico, E., Hohlfeld, R., Meinl, E., & Farina, C. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20110698 · Cited by 146
Hulshof, S. C. J., Montagne, L., Groot, C. J. A. D., & van der Valk, P. (2002) · Glia · doi:10.1002/glia.10050 · Cited by 143
Phosphorylated FTY720 promotes astrocyte migration through sphingosine-1-phosphate receptors
Müllershausen, F., Craveiro, L. M., Shin, Y., Cortés-Cros, M., Bassilana, F., Osinde, M., Wishart, W. L., Guerini, D., Thallmair, M., Schwab, M. E., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04629.x · Cited by 142
Reactive Oxygen Species from Human Astrocytes Induced Functional Impairment and Oxidative Damage
Sheng, W. S., Hu, S., Feng, A., & Rock, R. B. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1123-z · Cited by 139
Bullard, D. C., Hu, X., Schoeb, T. R., Collins, R. G., Beaudet, A. L., & Barnum, S. R. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.2.851 · Cited by 132
Thöne, J., Ellrichmann, G., Seubert, S., Peruga, I., Lee, D.-H., Conrad, R., Hayardeny, L., Comı, G., Wiese, S., Linker, R. A., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.09.037 · Cited by 131
Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosis
Baranzini, S. E., Srinivasan, R., Khankhanian, P., Okuda, D. T., Nelson, S. J., Matthews, P. M., Hauser, S. L., Oksenberg, J. R., & Pelletier, D. (2010) · Brain · doi:10.1093/brain/awq192 · Cited by 129
Haroon, F., Drögemüller, K., Händel, U., Brunn, A., Reinhold, D., Nishanth, G., Müller, W., Trautwein, C., Ernst, M., Deckert, M., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001135 · Cited by 128
Vogel, C. F. A., & Haarmann‐Stemmann, T. (2017) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2017.02.004 · Cited by 126
Thioredoxin as a Neurotrophic Cofactor and an Important Regulator of Neuroprotection
Masutani, H., Bai, J., Kim, Y., & Yodoi, J. (2004) · Molecular Neurobiology · doi:10.1385/mn:29:3:229 · Cited by 122
Wegner, C., Stadelmann, C., Pförtner, R., Raymond, E., Feigelson, S. W., Alon, R., Timan, B., Hayardeny, L., & Brück, W. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.07.009 · Cited by 121
Lafourcade, C., Ramírez, J. P., Luarte, A., Fernández, A., & Wyneken, Ú. (2016) · Journal of Experimental Neuroscience · doi:10.4137/jen.s39916 · Cited by 117
Dodel, R. C., Du, Y., Bales, K. R., Gao, F., & Paul, S. M. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731453.x · Cited by 114
Astrocyte‐associated axonal damage in pre‐onset stages of experimental autoimmune encephalomyelitis
Wang, D., Ayers, M. M., Catmull, D. V., Hazelwood, L. J., Bernard, C. C. A., & Orian, J. M. (2005) · Glia · doi:10.1002/glia.20199 · Cited by 112
Fessler, E. B., Chibane, F. L., Wang, Z., & Chuang, D. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319280009 · Cited by 110
Housley, W. J., Fernandez, S. D., Vera, K., Murikinati, S. R., Grutzendler, J., Cuerdon, N., Glick, L. R., Jager, P. L. D., Mitrovič, M., Cotsapas, C. J., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa9223 · Cited by 109
Multiple sclerosis: BAFF and CXCL13 in cerebrospinal fluid
Ragheb, S., Li, Y., Simon, K. W., VanHaerents, S. A., Galimberti, D., Riz, M. A. D., Fenoglio, C., Scarpini, E. A., & Lisak, R. P. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511398887 · Cited by 109
Human astrocytes are only partially competent antigen presenting cells
Weber, F., Meinl, E., Aloisi, F., et al. (1994) · Brain · doi:10.1093/brain/117.1.59 · Cited by 109
Choi, W.-H., Ji, K.-A., Jeon, S.-B., Yang, M.-S., Kim, H., Min, K.-J., Shong, M., Jou, I., & Joe, E. (2005) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2005.01.110 · Cited by 93
Lee, D.-H., Geyer, E., Flach, A., Jung, K., Gold, R., Flügel, A., Linker, R. A., & Lühder, F. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0890-3 · Cited by 92
Sticozzi, C., Belmonte, G., Meini, A., Carbotti, P., Grasso, G., & Palmi, M. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.07.061 · Cited by 91
Role of astrocytes in antigen presentation and naive T-cell activation
Cornet, A., Bettelli, E., Oukka, M., Cambouris, C., Avellana‐Adalid, V., Kosmatopoulos, K., & Liblau, R. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00215-5 · Cited by 90
Brennan, M. S., Matos, M. F., Richter, K. E., Li, B., & Scannevin, R. H. (2017) · Scientific Reports · doi:10.1038/srep42054 · Cited by 87
Luchetti, S., van Eden, C. G., Schuurman, K. G., van Strien, M. E., Swaab, D. F., & Huitinga, I. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000037 · Cited by 87
Fingolimod induces neuroprotective factors in human astrocytes
Hoffmann, F. S., Hofereiter, J., Rübsamen, H., Melms, J. C., Schwarz, S. C., Faber, H., Weber, P. C., Pütz, B., Loleit, V., Weber, F., et al. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0393-6 · Cited by 86
Multiple sclerosis Immunomodulatory effects of human astrocytes on T cells
Meinl, E., Aloisi, F., Ertl-Wagner, B. B., Weber, F., Malefyt, R. D. W., Wekerle, H., & Hohlfeld, R. (1994) · Brain · doi:10.1093/brain/117.6.1323 · Cited by 86
Zeinstra, E., Wilczak, N., & Keyser, J. D. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00462-9 · Cited by 85
Safety concerns and risk management of multiple sclerosis therapies
Sørensen, P. S. (2016) · Acta Neurologica Scandinavica · doi:10.1111/ane.12712 · Cited by 85
Enhanced astrocyte responses are driven by a genetic risk allele associated with multiple sclerosis
Ponath, G. D., Lincoln, M. R., Levine-Ritterman, M., Park, C., Dahlawi, S., Mubarak, M., Sumida, T. S., Airas, L. M., Zhang, S., Isitan, C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07785-8 · Cited by 84
Self-citationNeuroprotection by IFN-γviaastrocyte-secreted IL-6 in acute neuroinflammation
Sun, L., Li, Y., Jia, X., Wang, Q., Li, Y., Hu, M., Tian, L., Yang, J., Xing, W., Zhang, W., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16990 · Cited by 83
Dimethyl fumarate influences innate and adaptive immunity in multiple sclerosis
Diebold, M., Sievers, C., Bantug, G. R., Sanderson, N., Kappos, L., Kühle, J., Lindberg, R. L. P., & Derfuss, T. J. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.09.009 · Cited by 79
Gimsa, U., �ren, A., Pandiyan, P., Teichmann, D., Bechmann, I., Nitsch, R., & Brunner-Weinzierl, M. C. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0531-6 · Cited by 73
Saini, H. S., Coelho, R. P., Goparaju, S. K., Jolly, P. S., Maceyka, M. W., Spiegel, S., & Sato‐Bigbee, C. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03451.x · Cited by 69
Sato, K., Tomura, H., Igarashi, Y., Ui, M., & Okajima, F. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7666 · Cited by 69
Kipper‐Galperin, M., Gallily, R., Danenberg, H. D., & Brenner, T. (1999) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(99)00067-2 · Cited by 67
IL-1-induced iNOS expression in human astrocytes via NF-κB
Chao, C. C., Lokensgard, J. R., Sheng, W. S., Hu, S., & Peterson, P. K. (1997) · Neuroreport · doi:10.1097/00001756-199709290-00031 · Cited by 62
One more role for the gut: microbiota and blood brain barrier.
Michel, L., & Prat, A. (2016) · PubMed · doi:10.3978/j.issn.2305-5839.2015.10.16 · Cited by 61
Lactosylceramide: a lipid second messenger in neuroinflammatory disease
Won, J., Singh, A. K., & Singh, I. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04822.x · Cited by 61
Williams, W. M., Castellani, R. J., Weinberg, A., Perry, G. L., & Smith, M. A. (2012) · The Scientific World JOURNAL · doi:10.1100/2012/905785 · Cited by 56
Tallantyre, E. C., Evangelou, N., & Constantinescu, C. S. (2008) · PubMed · Cited by 55
D'Amelio, F. E., Smith, M. E., & Eng, L. F. (1990) · Glia · doi:10.1002/glia.440030402 · Cited by 54
Dual effects of daily FTY720 on human astrocytes in vitro: relevance for neuroinflammation
Wu, C., Leong, S. Y., Moore, C. S., Cui, Q., Gris, P., Bernier, L., Johnson, T., Séguéla, P., Kennedy, T. E., Bar‐Or, A., et al. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-41 · Cited by 51
Effects of fumarates on inflammatory human astrocyte responses and oligodendrocyte differentiation
Galloway, D. A., Williams, J. B., & Moore, C. S. (2017) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.414 · Cited by 51
MALCHINKHUU, E., SATO, K., MURAKI, T., ISHIKAWA, K., KUWABARA, A., & OKAJIMA, F. (2003) · Biochemical Journal · doi:10.1042/bj20020867 · Cited by 45
Rac1 Contributes to Maximal Activation of STAT1 and STAT3 in IFN-γ-Stimulated Rat Astrocytes
Park, E. J., Ji, K., Jeon, S., Choi, W.-H., Han, I., You, H. J., Kim, J., Jou, I., & Joe, E.-H. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.9.5697 · Cited by 44
Pham, H., Ramp, A. A., Klonis, N., Ng, S. W., Klopstein, A., Ayers, M. M., & Orian, J. M. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.12.010 · Cited by 39
Tenenbaum, M., Azab, A. N., & KAPLANSKI, J. (2007) · Journal of Endotoxin Research · doi:10.1177/0968051907080428 · Cited by 38
Fang, J., Han, D., Hong, J., Tan, Q., & Tian, Y. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-267 · Cited by 37
Astrocytes Exert and Control Immune Responses in the Brain
Cordiglieri, C., & Farina, C. (2010) · Current Immunology Reviews · doi:10.2174/157339510791823655 · Cited by 32
Santello, M., & Volterra, A. (2010) · Nature · doi:10.1038/463169a · Cited by 32
Kim, J. A., Yun, H., Jin, P., Lee, H. P., Han, J. Y., Udumula, V., Moon, D. C., Han, S., Oh, K. W., Ham, Y. W., et al. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.06.032 · Cited by 18
Defensins and Mucosal Protection
Mahida, Y. R., & Cunliffe, R. (2004) · Novartis Foundation symposium · doi:10.1002/0470090480.ch6 · Cited by 17
Barkhof, F., Giovannoni, G., Hartung, H., Cree, B., Uccelli, A., Sormani, M. P., Krieger, S. C., Uitdehaag, B. M. J., Vollmer, T. R., Montalbán, X., et al. (2015) · Neurology · doi:10.1212/wnl.84.14_supplement.p7.210 · Cited by 9
Fingolimod failure in progressive MS INFORMS future trials
Smith, A. L., & Cohen, J. A. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.37 · Cited by 9
Cited by
The blood-brain barrier in aging and neurodegeneration
Knox, E. G., Aburto, M. R., Clarke, G., Cryan, J. F., & O’Driscoll, C. M. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01511-z · Cited by 738
Moving beyond the glial scar for spinal cord repair
Bradbury, E. J., & Burnside, E. R. (2019) · Nature Communications · doi:10.1038/s41467-019-11707-7 · Cited by 743
Astrocytes in human central nervous system diseases: a frontier for new therapies
Verkhratsky, A., Butt, A., Li, B., Illes, P., Zorec, R., Semyanov, A., Tang, Y., & Sofroniew, M. V. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01628-9 · Cited by 428
Preterm birth and sustained inflammation: consequences for the neonate
Humberg, A., Fortmann, I., Siller, B., Kopp, M. V., Herting, E., Göpel, W., Härtel, C., & German Neonatal Network, G. C. F. L. R. A. P. I. A. T. B. O. L. (. C. (2020) · Seminars in Immunopathology · doi:10.1007/s00281-020-00803-2 · Cited by 310
Circular RNAs in immune responses and immune diseases
Chen, X., Yang, T., Wang, W., Xi, W., Zhang, T., Li, Q., Yang, A., & Wang, T. (2019) · Theranostics · doi:10.7150/thno.29678 · Cited by 290
Metadata
- Authors
- Ponath, G., Park, C., & Pitt, D.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2018-02-19
- Volume
- 9
- Pages
- 217-217
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2793453767
- Cited by
- 359
- References
- 183
- FWCI
- 23.78
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.